Cegedim

CGM

FR0000053506

Software

Market Closed - Euronext Paris Other stock markets 11:35:01 2024-07-12 am EDT			5-day change	1st Jan Change
12.95 ^EUR	-0.77%		-3.36%	-27.49%

May. 03	Cegedim: contract for Claude Bernard in Wallonia	CF
Apr. 26	Cegedim: 7% sales growth in Q1	CF

Cegedim SA Provides Revenue Guidance for the Year 2021

January 26, 2021 at 11:45 am EST

Cegedim SA provided revenue guidance for the year 2021. For 2021, the Group expects like-for-like revenue growth of c.2%.

Latest news about Cegedim

Cegedim: contract for Claude Bernard in Wallonia	May. 03	CF
Cegedim: 7% sales growth in Q1	Apr. 26	CF
Transcript : Cegedim SA, Q1 2024 Sales/ Trading Statement Call, Apr 25, 2024	Apr. 25
Cegedim: 23% increase in ROC in 2023	Mar. 28	CF
Cegedim SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Transcript : Cegedim SA, 2023 Earnings Call, Mar 27, 2024	Mar. 27
Cegedim SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Cegedim: acquisition in the dental care sector	Feb. 16	CF
Cegedim Buys French Dental Software Company Visiodent	Feb. 16	MT
Cegedim: certification obtained for data centers	Feb. 02	CF
Cegedim: 8% sales growth in Q4	Jan. 26	CF
Cegedim: investment in start-up Phealing	Nov. 30	CF
Cegedim SA acquired unknown majority stake in Phealing.	Nov. 29	CI
Cegedim: THIN database extended to Germany	Nov. 13	CF
Cegedim: a scientific committee created for THIN	Nov. 07	CF
Cegedim: growth confirmed, targets maintained	23-10-27	CF
Cegedim Provides Revenue Guidance for the Full Year 2023	23-10-26	CI
Cegedim: successful partnership with Shift Technology	23-10-10	CF
Cegedim launches partnership with adeRHis	23-09-26	CF
Cegedim: net loss widens in 1st half	23-09-21	CF
Cegedim SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-20	CI
Cegedim SA Provides Revenue Guidance for the Full Year 2023	23-07-27	CI
Cegedim: new partnership with Gustave Roussy	23-06-02	CF
Cegedim: final ACPR approval for CETIP	23-05-26	CF
Cegedim: confident for fiscal 2023, share price rises	23-04-28	CF

Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (72.1%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (26.8%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (1.1%). France accounts for 89.7% of net sales.

Sector

Software

Calendar

2024-07-24 - Q2 2024 Sales and Revenue Release

More about the company

Income Statement Evolution

More financial data

Ratings for Cegedim

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

12.95 EUR

Average target price

18.03 EUR

Spread / Average Target

+39.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Enterprise Software

	1st Jan change	Capi.
CEGEDIM	-27.49%	193M
ORACLE CORPORATION	+37.15%	399B
SAP SE	+35.32%	239B
SERVICENOW, INC.	+7.36%	156B
CONSTELLATION SOFTWARE INC.	+26.23%	64.55B
FAIR ISAAC CORPORATION	+36.47%	39.25B
MICROSTRATEGY INCORPORATED	+121.14%	24.77B
HUBSPOT, INC.	-17.98%	24.26B
WISETECH GLOBAL LIMITED	+26.43%	21.41B
TRIMBLE, INC.	+7.80%	14.01B

Enterprise Software

Cegedim

Equities

CGM

FR0000053506

Software

Cegedim SA Provides Revenue Guidance for the Year 2021

Latest news about Cegedim

Chart Cegedim

Company Profile

Income Statement Evolution

Ratings for Cegedim

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Enterprise Software